Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Evotec SE: A reportable insider transaction was published on 22nd August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd August 2024,
The Insider Transaction was made by Johnstone, Dr. Craig 
. The transaction toke place on 22nd August 2024. The order was executed at the trading place XETA. . The aggregated volume was 16.553,03 EUR, based on an average price of 5,52 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 8th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 8th August 2024,
The Insider Transaction was made by Cordola, Craig . The transaction toke place on 7th August 2024. The order was executed at the trading place NYSE. . The aggregated volume was 495.859,06 USD, based on an average price of 18,15 USD. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 26th February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th February 2024,
The Insider Transaction was made by Cordola, Craig . The transaction toke place on 23rd February 2024. The order was executed at the trading place NYSE. . The aggregated volume was 611.268,18 USD, based on an average price of 19,32 USD. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 23rd February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 23rd February 2024,
The Insider Transaction was made by Cordola, Craig . The transaction toke place on 22nd February 2024. The order was executed at the trading place NYSE. . The aggregated volume was 386.018,55 USD, based on an average price of 19,37 USD. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 18th January 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th January 2024,
The Insider Transaction was made by Johnstone, Dr. Craig . The transaction toke place on 16th January 2024. . The aggregated volume was 51.611,51 EUR, based on an average price of 15,49 EUR. The nature of the Investment was not specified.
Evotec SE: A reportable insider transaction was published on 18th January 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th January 2024,
The Insider Transaction was made by Johnstone, Dr. Craig . The transaction toke place on 16th January 2024. . The aggregated volume was 51.596,02 EUR, based on an average price of 15,49 EUR. The nature of the Investment was not specified.
Evotec SE: A reportable insider transaction was published on 18th January 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th January 2024,
The Insider Transaction was made by Johnstone, Dr. Craig . The transaction toke place on 15th January 2024. . The aggregated volume was 42.730,20 EUR, based on an average price of 14,76 EUR. The nature of the Investment was not specified.
Evotec SE: A reportable insider transaction was published on 18th January 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th January 2024,
The Insider Transaction was made by Johnstone, Dr. Craig . The transaction toke place on 15th January 2024. . The aggregated volume was 42.715,44 EUR, based on an average price of 14,76 EUR. The nature of the Investment was not specified.
Evotec SE: A reportable insider transaction was published on 20th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 20th January 2023,
The Insider Transaction was made by Johnstone, Dr. Craig . The transaction toke place on 19th January 2023. . The aggregated volume was 173.415,65 EUR, based on an average price of 17,94 EUR. The nature of the Investment was not specified.
Evotec SE: A reportable insider transaction was published on 20th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 20th January 2023,
The Insider Transaction was made by Johnstone, Dr. Craig . The transaction toke place on 19th January 2023. . The aggregated volume was 173.397,70 EUR, based on an average price of 17,94 EUR. The nature of the Investment was not specified.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.